Clinical Trial

The PEERLESS II Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE.
Protocol Amendment History 4 changes
notable Primary completion pushed: 2026-07 -> 2026-08 2026-08-07
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-15
notable Trial sites reduced: 83 -> 77 locations 2026-07-15
minor Completion pushed: 2026-07 -> 2026-10 2026-07-15
Trial Details
NCT Number NCT06055920
Lead Sponsor Inari Medical
Conditions Pulmonary Embolism
Enrollment 1,200 participants
Start Date 2023-11-17
Primary Completion 2026-08 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-08-06